7-hydroxy-3,4-dihydrocadalin
from Heterotheca inuloides; structure given in first source
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
| 1. | Hyperalgesia
04/07/2014
- " Oral acute administration of 7-hydroxy-3,4-dihydrocadalin (0.3-30 mg/kg) decreased in a dose-dependent manner formalin-evoked hyperalgesia in diabetic rats. " 04/07/2014
- " Finally, chronic oral administration of 7-hydroxy-3,4-dihydrocadalin (30-300 mg/kg, 3 times/week, during 6 weeks), significantly prevented the development of mechanical hyperalgesia and allodynia in streptozotocin-induced diabetic mice. " 04/07/2014
- " At this time, oral administration of 7-hydroxy-3,4-dihydrocadalin (30 mg/kg) or pregabalin (10 mg/kg) reduced in a similar way tactile allodynia in diabetic rats. " 12/15/2010
- " In addition, 7-hydroxy-3,4-dihydrocadalin reduced carrageenan-induced mechanical hyperalgesia and inflammation in a dose-dependent manner. "
|
| 2. | Inflammation (Inflammations)
|
| 3. | Hemolysis
|
| 4. | Diabetic Neuropathies (Diabetic Neuropathy)
|
|
Related Drugs and Biologics
Related Therapies and Procedures